• レポートコード:GIR-105X07146 • 出版社/出版日: / 2021年5月 • レポート形態:英文、PDF、93ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:Medical Devices & Consumables |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、フルデオキシグルコース(18F)放射性核種注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フルデオキシグルコース(18F)放射性核種注射の種類別市場規模(滅菌、非滅菌)、用途別市場規模(病院、クリニック、診断センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・フルデオキシグルコース(18F)放射性核種注射の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Zevacor Pharma、Queen's PET Imaging、Triad Isotopes、NCM USA Bronx、Spectron MRC、Petnet Solutions、Shertech Laboratories、Precision Nuclear ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:滅菌、非滅菌 ・用途別分析2016年-2026年:病院、クリニック、診断センター ・フルデオキシグルコース(18F)放射性核種注射の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・フルデオキシグルコース(18F)放射性核種注射のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・フルデオキシグルコース(18F)放射性核種注射のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・フルデオキシグルコース(18F)放射性核種注射の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・フルデオキシグルコース(18F)放射性核種注射の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fludeoxyglucose (18F) Radionuclide Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Fludeoxyglucose (18F) Radionuclide Injection size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Fludeoxyglucose (18F) Radionuclide Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Fludeoxyglucose (18F) Radionuclide Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sterile
Non-sterile
Market segment by Application can be divided into
Hospitals
Clinics
Diagnostics Center
The key market players for global Fludeoxyglucose (18F) Radionuclide Injection market are listed below:
Zevacor Pharma
Queen’s PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Fludeoxyglucose (18F) Radionuclide Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fludeoxyglucose (18F) Radionuclide Injection, with price, sales, revenue and global market share of Fludeoxyglucose (18F) Radionuclide Injection from 2019 to 2021.
Chapter 3, the Fludeoxyglucose (18F) Radionuclide Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fludeoxyglucose (18F) Radionuclide Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Fludeoxyglucose (18F) Radionuclide Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Fludeoxyglucose (18F) Radionuclide Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Fludeoxyglucose (18F) Radionuclide Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sterile
1.2.3 Non-sterile
1.3 Market Analysis by Application
1.3.1 Overview: Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Center
1.4 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size & Forecast
1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Value (2016-2026))
1.4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume (2016-2026)
1.4.3 Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2016-2026) & (USD/g)
1.5 Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity Analysis
1.5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Total Production Capacity (2016-2026)
1.5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fludeoxyglucose (18F) Radionuclide Injection Market Drivers
1.6.2 Fludeoxyglucose (18F) Radionuclide Injection Market Restraints
1.6.3 Fludeoxyglucose (18F) Radionuclide Injection Trends Analysis
2 Manufacturers Profiles
2.1 Zevacor Pharma
2.1.1 Zevacor Pharma Details
2.1.2 Zevacor Pharma Major Business
2.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.1.4 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Queen’s PET Imaging
2.2.1 Queen’s PET Imaging Details
2.2.2 Queen’s PET Imaging Major Business
2.2.3 Queen’s PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.2.4 Queen’s PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Triad Isotopes
2.3.1 Triad Isotopes Details
2.3.2 Triad Isotopes Major Business
2.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.3.4 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 NCM USA Bronx
2.4.1 NCM USA Bronx Details
2.4.2 NCM USA Bronx Major Business
2.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.4.4 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Spectron MRC
2.5.1 Spectron MRC Details
2.5.2 Spectron MRC Major Business
2.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.5.4 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Petnet Solutions
2.6.1 Petnet Solutions Details
2.6.2 Petnet Solutions Major Business
2.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.6.4 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shertech Laboratories
2.7.1 Shertech Laboratories Details
2.7.2 Shertech Laboratories Major Business
2.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.7.4 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Precision Nuclear
2.8.1 Precision Nuclear Details
2.8.2 Precision Nuclear Major Business
2.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Product and Services
2.8.4 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Fludeoxyglucose (18F) Radionuclide Injection Sales by Manufacturer
3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Fludeoxyglucose (18F) Radionuclide Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share
3.4.2 Top 6 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share
3.5 Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Fludeoxyglucose (18F) Radionuclide Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size by Region
4.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2016-2026)
4.2 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026)
4.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026)
4.4 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026)
4.5 South America Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026)
4.6 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Type (2016-2026)
5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2016-2026)
5.3 Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Application (2016-2026)
6.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2016-2026)
6.3 Global Fludeoxyglucose (18F) Radionuclide Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2026)
7.2 North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2026)
7.3 North America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
7.3.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2026)
8.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2026)
8.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
8.3.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Market Size by Region
9.3.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2026)
10.2 South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2026)
10.3 South America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
10.3.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
11.3.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Fludeoxyglucose (18F) Radionuclide Injection Typical Distributors
12.3 Fludeoxyglucose (18F) Radionuclide Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Zevacor Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Zevacor Pharma Major Business
Table 5. Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 6. Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Queen's PET Imaging Basic Information, Manufacturing Base and Competitors
Table 8. Queen's PET Imaging Major Business
Table 9. Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 10. Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 12. Triad Isotopes Major Business
Table 13. Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 14. Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. NCM USA Bronx Basic Information, Manufacturing Base and Competitors
Table 16. NCM USA Bronx Major Business
Table 17. NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 18. NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Spectron MRC Basic Information, Manufacturing Base and Competitors
Table 20. Spectron MRC Major Business
Table 21. Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 22. Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Petnet Solutions Basic Information, Manufacturing Base and Competitors
Table 24. Petnet Solutions Major Business
Table 25. Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 26. Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shertech Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Shertech Laboratories Major Business
Table 29. Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 30. Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Precision Nuclear Basic Information, Manufacturing Base and Competitors
Table 32. Precision Nuclear Major Business
Table 33. Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Product and Services
Table 34. Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Manufacturer (2019-2021e) & (Kg)
Table 36. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Fludeoxyglucose (18F) Radionuclide Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity by Company, (Kg): 2020 VS 2021
Table 39. Head Office and Fludeoxyglucose (18F) Radionuclide Injection Production Site of Key Manufacturer
Table 40. Fludeoxyglucose (18F) Radionuclide Injection New Entrant and Capacity Expansion Plans
Table 41. Fludeoxyglucose (18F) Radionuclide Injection Mergers & Acquisitions in the Past Five Years
Table 42. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Region (2016-2021e) & (Kg)
Table 43. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Region (2021-2026) & (Kg)
Table 44. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 47. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 48. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2016-2021e) & (USD/g)
Table 51. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2021-2026) & (USD/g)
Table 52. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 53. Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 54. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Application (2016-2021e) & (USD/g)
Table 57. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Application (2021-2026) & (USD/g)
Table 58. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2016-2021e) & (Kg)
Table 59. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2021-2026) & (Kg)
Table 60. North America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 63. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 64. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 65. North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 66. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2016-2021e) & (Kg)
Table 67. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2021-2026) & (Kg)
Table 68. Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 71. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 72. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 73. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 74. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Region (2016-2021e) & (Kg)
Table 75. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Region (2021-2026) & (Kg)
Table 76. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 79. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 80. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 81. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 82. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2016-2021e) & (Kg)
Table 83. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2021-2026) & (Kg)
Table 84. South America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 87. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 88. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 89. South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 90. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2016-2021e) & (Kg)
Table 91. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2021-2026) & (Kg)
Table 92. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2016-2021e) & (Kg)
Table 95. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2021-2026) & (Kg)
Table 96. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2016-2021e) & (Kg)
Table 97. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2021-2026) & (Kg)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Fludeoxyglucose (18F) Radionuclide Injection Typical Distributors
Table 101. Fludeoxyglucose (18F) Radionuclide Injection Typical Customers
List of Figures
Figure 1. Fludeoxyglucose (18F) Radionuclide Injection Picture
Figure 2. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type in 2020
Figure 3. Sterile
Figure 4. Non-sterile
Figure 5. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Diagnostics Center
Figure 9. Global Fludeoxyglucose (18F) Radionuclide Injection Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 10. Global Fludeoxyglucose (18F) Radionuclide Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Fludeoxyglucose (18F) Radionuclide Injection Sales (2016-2026) & (Kg)
Figure 12. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2016-2026) & (USD/g)
Figure 13. Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity (2016-2026) & (Kg)
Figure 14. Global Fludeoxyglucose (18F) Radionuclide Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Fludeoxyglucose (18F) Radionuclide Injection Market Drivers
Figure 16. Fludeoxyglucose (18F) Radionuclide Injection Market Restraints
Figure 17. Fludeoxyglucose (18F) Radionuclide Injection Market Trends
Figure 18. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Manufacturer in 2020
Figure 19. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Manufacturer in 2020
Figure 20. Fludeoxyglucose (18F) Radionuclide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Region (2016-2026)
Figure 24. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Region (2016-2026)
Figure 25. North America Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026) & (USD Million)
Figure 26. Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026) & (USD Million)
Figure 28. South America Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue (2016-2026) & (USD Million)
Figure 30. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2016-2026)
Figure 31. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Type (2016-2026)
Figure 32. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2016-2026) & (USD/g)
Figure 33. Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 34. Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Application (2016-2026)
Figure 35. Global Fludeoxyglucose (18F) Radionuclide Injection Price by Application (2016-2026) & (USD/g)
Figure 36. North America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2016-2026)
Figure 37. North America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 38. North America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Country (2016-2026)
Figure 39. North America Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Country (2016-2026)
Figure 40. United States Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2016-2026)
Figure 44. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 45. Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Country (2016-2026)
Figure 46. Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Country (2016-2026)
Figure 47. Germany Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Region (2016-2026)
Figure 56. China Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2016-2026)
Figure 63. South America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 64. South America Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Country (2016-2026)
Figure 65. South America Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source